Vertex to participate in upcoming june investor conferences

Boston--(business wire)--vertex pharmaceuticals incorporated (nasdaq: vrtx) today announced management participation in two upcoming investor conferences. dr. reshma kewalramani, chief executive officer and president, will present at the william blair 44th annual growth stock conference on tuesday, june 4, 2024 at 4:00 p.m. ct. charles wagner, executive vice president and chief financial officer, and david altshuler, m.d., ph.d., executive vice president, global research, and chief scientific o.
VRTX Ratings Summary
VRTX Quant Ranking